HERNEXEOS

ZONGERTINIB · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HERNEXEOS, covering 2025-08-08 to 2026-07-31. Get the full timeline:

Most recent: FDA Approved: HERNEXEOS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)